Group One Trading’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-100
| Closed | -$1.19K | – | 8108 |
|
|
2025
Q3 | $728 | Buy |
+100
| New | +$677 | ﹤0.01% | 8104 |
|
|
2025
Q1 | – | Sell |
-32,290
| Closed | -$289K | – | 7562 |
|
|
2024
Q4 | $289K | Buy |
32,290
+14,969
| +86% | +$159K | ﹤0.01% | 3619 |
|
|
2024
Q3 | $191K | Buy |
17,321
+6,865
| +66% | +$76.3K | ﹤0.01% | 3657 |
|
|
2024
Q2 | $95.2K | Sell |
10,456
-21,150
| -67% | -$206K | ﹤0.01% | 4007 |
|
|
2024
Q1 | $445K | Buy |
31,606
+29,042
| +1,133% | +$362K | ﹤0.01% | 2854 |
|
|
2023
Q4 | $19.7K | Sell |
2,564
-636
| -20% | -$3.52K | ﹤0.01% | 5758 |
|
|
2023
Q3 | $23.9K | Buy |
+3,200
| New | +$27.3K | ﹤0.01% | 5746 |
|
|
2023
Q1 | – | Sell |
-9,871
| Closed | -$133K | – | 7184 |
|
|
2022
Q4 | $147K | Buy |
9,871
+1,371
| +16% | +$14.1K | ﹤0.01% | 4111 |
|
|
2022
Q3 | $77K | Sell |
8,500
-2,931
| -26% | -$19.6K | ﹤0.01% | 5025 |
|
|
2022
Q2 | $34K | Hold |
11,431
| – | – | ﹤0.01% | 5881 |
|
|
2022
Q1 | $77K | Buy |
11,431
+9,131
| +397% | +$54.4K | ﹤0.01% | 5743 |
|
|
2021
Q4 | $12K | Buy |
+2,300
| New | +$15.1K | ﹤0.01% | 7260 |
|
|
2021
Q3 | – | Sell |
-14,201
| Closed | -$136K | – | 8151 |
|
|
2021
Q2 | $180K | Sell |
14,201
-2,659
| -16% | -$34.5K | ﹤0.01% | 5344 |
|
|
2021
Q1 | $292K | Buy |
+16,860
| New | +$305K | ﹤0.01% | 4604 |
|
|
2020
Q4 | – | Sell |
-1,323
| Closed | -$23.6K | – | 6470 |
|
|
2020
Q3 | $49K | Buy |
+1,323
| New | +$52.4K | ﹤0.01% | 4655 |
|
Group One Trading's ATXS Position: Q4 2025 in Review
Group One Trading sold out of Astria Therapeutics (ATXS) in Q4 2025, closing a stake of 100 shares — an estimated $1.19K sold.
Group One Trading first reported a position in ATXS in Q3 2020 and held it in 15 quarters. The position peaked at $445K in Q1 2024. 141 funds tracked by Wall St. Rank hold ATXS as of Q4 2025.
- Group One Trading reported no remaining Astria Therapeutics position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 100 Astria Therapeutics shares in Q4 2025, an estimated $1.19K.
- Group One Trading first reported a position in Astria Therapeutics in Q3 2020 and held it in 15 quarters.
- Group One Trading's Astria Therapeutics position peaked at $445K in Q1 2024.
- 141 funds tracked by Wall St. Rank held Astria Therapeutics as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.